
Bak, NT (BAK1, BCL2-antagonist/killer 1, BAK, CDN1, BCL2L7, celdoodremmer 1, apoptosisregulator BAK, Bcl-2 homologe antagonist/killer) (PE)
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
[Bak]
578
Human, Mouse, Rat
Store product at 4 degree C in the dark. DO NOT FREEZE! Stable at 4 degree C for 12 months after receipt as an undiluted liquid. Dilute required amount only prior to immediate use. Further dilutions can be made in assay buffer. Caution: PE conjugates are sensitive to light. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Recognizes human Bak. Species Crossreactivity: rat, mouse
[BAK1; BAK1; BAK; CDN1; BCL2L7; BAK-LIKE; BAK; BCL2L7; CDN1; Bcl2-L-7]
[Bak]
[bcl-2 homologous antagonist/killer; Bcl-2 homologous antagonist/killer; bcl-2 homologous antagonist/killer; bcl2-L-7; BCL2-like 7 protein; bcl-2-like protein 7; apoptosis regulator BAK; pro-apoptotic protein BAK; BCL2-antagonist/killer 1; Apoptosis regulator BAK; Bcl-2-like protein 7]
4502363
NP_001179.1
NM_001188
Q16611
Beschrijving
Bak, NT (BAK1, BCL2-antagonist/killer 1, BAK, CDN1, BCL2L7, celdoodremmer 1, apoptosisregulator BAK, Bcl-2 homologe antagonist/killer) (PE) Beschikbaar in 0.1 m
Specificaties
Recent bekeken producten

0.22μm Syringe Filter
F1021
13mm, 50 / Pk, 500 / Cs

Erdafitinib
B2458-25
25 mg

TRPM4-IN-2
BA7024-1
1 mg

TRPM4-IN-1
HY-122605-01
5 mg

Anti-RAVV Envelope glycoprotein/GP Recombinant Antibody (SAA2752)
VK160013-01
50 µg

Recombinant BoHV-1 Envelope glycoprotein E
DRA167-01
50 µg

GelRed® Agarose LE
#41029-5G
1x 5 g

50 ml Disposable Serological Pipette
CPP00050
100/CS
Recent gezochte producten

Syringe Filters
CS0037
1 Each

Syringe Filters
4013780/1A
1 Each

Syringe Filters
4013780/A
1 Each

0.22μm Syringe Filter
F1021
13mm, 50 / Pk, 500 / Cs

0.22μm Syringe Filter
F1221
13mm, 50 / Pk, 500 / Cs

0.22μm Syringe Filter
F1422
25mm, purple, 50 / Pk, 500 / Cs

0.45μm Syringe Filter
F1442
25mm, 50 / Pk, 500 / Cs

0.22μm Syringe Filter
F1122
25mm, 50 / Pk, 500 / Cs
